Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons J.F. (Jiske) Tiersma

Publicaties

Everolimus decreases [U-13C]glucose utilization by pyruvate carboxylase in breast cancer cells in vitro and in vivo.

Repurposing metabolic inhibitors for cancer treatment: towards improving the antitumour immune response

Targeting tumour metabolism in melanoma to enhance response to immune checkpoint inhibition: A balancing act

Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities

Combined in vivo C-13-metabolomics and proteomics approach to optimise immunotherapy response in malignant melanoma.

Targeting metabolism to improve response to immune-checkpoint inhibition in melanoma.

Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade